Justyna Kelly

Chief Operating Officer bij POINT Biopharma, Inc. (United States)

39 jaar

Consumer Services

Health Technology

Commercial Services

Actieve functies van Justyna Kelly

Bedrijven	Functie	Begin	Einde
POINT Biopharma, Inc. (United States) POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.	Chief Operating Officer	-	-

Bedrijven	Functie	Begin	Einde
POIT BIOP	Chief Operating Officer	01-12-2021	27-12-2023
POIT BIOP	Corporate Officer/Principal	30-06-2021	01-12-2021

McMaster University

Graduate Degree

Internationaal

Verenigde Staten	3
Canada	2

Operationeel

Chief Operating Officer	2
Corporate Officer/Principal	1
Graduate Degree	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
POIT BIOP	Health Technology

Bedrijven in privébezit	1
POINT Biopharma, Inc. (United States) POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.	Commercial Services

Bedrijven in privébezit

Commercial Services